# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Janney Montgomery Scott analyst John Rodis upgrades CrossFirst Bankshares (NASDAQ:CFB) from Neutral to Buy and announces $21...
Keefe, Bruyette & Woods analyst Wood Lay maintains CrossFirst Bankshares (NASDAQ:CFB) with a Outperform and maintains $2...
First Busey Corporation ("Busey") (NASDAQ:BUSE), the holding company for Busey Bank, and CrossFirst Bankshares, Inc. (&...
Keefe, Bruyette & Woods analyst Wood Lay reiterates CrossFirst Bankshares (NASDAQ:CFB) with a Outperform and raises the ...
US regional banks gain as investors rotate from large-cap to small-cap stocks, with the SPDR S&P Regional Banking ETF rally...
Stephens & Co. analyst Matt Olney reiterates CrossFirst Bankshares (NASDAQ:CFB) with a Overweight and maintains $17 pric...
SILO: 143% | Silo Pharma Obtains Exclusive Global License To Develop, Manufacture, And Commercialize Its Alzheimer's Drug G...